Opexa Therapeutics to Present Progress on Development of Monocyte-Derived Pancreatic Islet Cells for Diabetes
Business Wire via Yahoo! Finance Mon, 07 May 2007 4:00 AM PDT
THE WOODLANDS, Texas----Opexa Therapeutics, Inc. , a company involved in the development and commercialization of cell therapies, will make presentations at two scientific meetings in Australia in June that demonstrate significant advancement of Opexa's human stem cell program to develop human monocyte-derived stem cell therapies for the treatment of human diseases such as diabetes.

NeoStem Announces CareCredit, a GE Money Company, to Offer Clients Financing Payment Options for Stem Cell Collection ...
RedNova Mon, 07 May 2007 2:01 AM PDT
NeoStem, Inc. (OTCBB:NEOI), the first company t

Ultra-High-Field MRI Allows for Earlier Diagnosis of Multiple Sclerosis
Newswise Sun, 06 May 2007 10:21 PM PDT
Ultra-high-field (7T) MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment, according to a new study by researchers from Ohio State University in Columbus, and Columbia University in New York.

Immediate Treatment Of Early MS Patients With Betaferon? Significantly Delayed Permanent Disability Medical News Today Mon, 07 May 2007 0:10 AM PDT Bayer Schering Pharma AG, Germany, announced today new data, which show that immediate initiation of Betaferon? (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) can significantly reduce the risk of permanent neurological impairment as measured by [click link for full article]

Brain's white matter -- More 'talkative' than once thought
EurekAlert! Mon, 07 May 2007 6:37 AM PDT
Johns Hopkins scientists have discovered to their surprise that nerves in the mammalian brain?s white matter do more than just ferry information between different brain regions, but in fact process information the way gray matter cells do.